Search Results

You searched for : HIV-1  

The Deadly 17: WHO�s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for ...
Nov 09

Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study

Lungershausen said Avance Clinical is focussed on accelerating drug development for its biotech clients, from preclinical stages through to Phase III....
Mar 29

Coronavirus vs. Human immunodeficiency virus - Medicircle

Know the major difference between the Coronavirus (COVID-19) and Human Immunodeficiency Virus (HIV). Furthermore, learn about the ways in which one can protect themselves ...
Mar 29

ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe

Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV...
Jan 15

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left....
Dec 11

Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1

Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option with Focus on Women...
Nov 16

ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe

Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children...
Nov 13

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ...
Oct 16

GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients

GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients...
Oct 09

Merck Announces Week 96 Data from Phase 2b Study Evaluating Islatravir With Doravirine for HIV-1

Merck, today announced Week 96 data from the Phase 2b trial evaluating the efficacy and safety of islatravir for HIV-1 infections...
Oct 08

ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naïve adults with HIV-1

Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy...
Oct 05

ViiV Healthcare to present long-term safety and efficacy data for 2-drug regimen

Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ...
Oct 01

USFDA approves Roche's Cobas 6800/8800 systems also for HIV Tests

Cobas 6800/8800 gets USFDA approval for the machines are also being used in India for Covid detection...
Sep 05

ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV

CABENUVA reduces treatment dosing days from 365 to 12 per year ​...
Mar 21

A new strain of HIV infection found after about 20 years

New starin of HIV detected...
Jan 25

17 Matching result(s) found!

-Advertisements-




Trending Now

India on the Boil: Unmasking the Heatwave Crisis and the Cooling Power of Traditional WisdomApril 25, 2025
The Creamy Culprit: How Raw Egg Mayonnaise Became a Public Health Hazard in IndiaApril 25, 2025
The Invisible Childhood Enemy Behind Young Adult Colon CancerApril 25, 2025
TERN Group charts the future of ethical nurse migration with scalable impact.April 25, 2025
6 Gut-Friendly Foods That Soothe an Irritated StomachApril 25, 2025
Top 5 IVF Centres in India – Best IVF Clinics for Fertility TreatmentApril 25, 2025
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025April 25, 2025
World Malaria Day: Why India Must Not Let Its Guard DownApril 25, 2025
Murder in the Name of God: Kashmir and the Collapse of HumanityApril 24, 2025
6 Early Warning Signs of Malaria You Shouldn’t IgnoreApril 24, 2025
World Meningitis Day: A Loud Alarm for a Quiet KillerApril 24, 2025
Amid Documented Progress, India’s Malaria-Free Dream Faces Ground Realities.April 24, 2025
Medanta Surgeons Remove Rare Tumour, Rebuild Face of Iraqi Toddler in 14-Hour Surgery.April 24, 2025
Burnett Homeopathy Hosts Historic World Homeopathy Summit 3 During World Homeopathy Week in Germany April 24, 2025
Mind Over Meltdown: The Underrated Skill Saving Relationships and SanityApril 23, 2025
Moscow Accelerates AI Testing in Healthcare with New Diagnostic MethodApril 23, 2025
The Weight Loss Drug That Could Weigh Down Your Mind: A Closer Look at Ozempic’s Hidden CostApril 23, 2025
The Chaos That Makes You Human: How Disorder in the Brain Creates Order in ThoughtApril 23, 2025
Benefiting 7,000 Children Across 30 Schools with CSR InitiativesApril 23, 2025
MGM Healthcare Performs Life-Saving Surgery on 6-Year-Old Boy with Severe Heart BlockageApril 23, 2025